Skip to main navigation menu Skip to main content Skip to site footer

Effects of amitraz plus-Parapoxvirus ovis on EGF, VEGF, IGF-1 and IGF-2 in canine generalized demodicosis

Efectos de amitraz más Parapoxvirus ovis sobre EGF, VEGF, IGF-1 e IGF-2 en la demodicosis generalizada canina



How to Cite
Yarim, G. F., Pekmezci, D. ., Yarim, M. ., Bekir Yagci, B. ., Gokceoglu, A. ., Sozmen, M. ., Zafer Pekmezci, G. ., Karaca, E. ., & Guzel, M. . (2024). Effects of amitraz plus-Parapoxvirus ovis on EGF, VEGF, IGF-1 and IGF-2 in canine generalized demodicosis. Journal MVZ Cordoba, 27(3), e2619. https://doi.org/10.21897/rmvz.2619

Dimensions
PlumX

Gul Fatma Yarim,

Universidad Ondokuz Mayis, Facultad de Medicina Veterinaria, Departamento de Bioquímica, Samsun, Turkey.


Didem Pekmezci,

Universidad Ondokuz Mayis, Facultad de Medicina Veterinaria, Departamento de Medicina Interna, Samsun, Turkey.


Murat Yarim,

Universidad Ondokuz Mayis, Facultad de Medicina Veterinaria, Departamento de Patología, Samsun, Turkey.


Bugrahan Bekir Yagci,

Universidad Kirikkale, Facultad de Medicina Veterinaria, Departamento de Medicina Interna, Kirikkale, Turkey.


Ayris Gokceoglu,

Universidad Ondokuz Mayis, Facultad de Medicina Veterinaria, Departamento de Bioquímica, Samsun, Turkey.


Mahmut Sozmen,

Universidad Ondokuz Mayis, Facultad de Medicina Veterinaria, Departamento de Patología, Samsun, Turkey.


Gokmen Zafer Pekmezci,

Universidad Ondokuz Mayis, Facultad de Medicina Veterinaria, Departamento de Patología, Samsun, Turkey.


Efe Karaca,

Universidad Ondokuz Mayis, Facultad de Medicina Veterinaria, Departamento de Medicina Interna, Samsun, Turkey.


Murat Guzel,

Universidad Ondokuz Mayis, Facultad de Medicina Veterinaria, Departamento de Medicina Interna, Samsun, Turkey.


Objective. The purpose of the study is to investigate the effect of treatment with amitraz plus-Parapoxvirus ovis (IPPVO) on serum concentrations and skin expressions of insulin-like growth factor (IGF)-1 and -2, epidermal growth factor (EGF), vascular endothelial growth factor (VEGF), in dogs suffering from generalised demodicosis (GD). Materials and Methods. Generalised demodicosis affected dogs were injected 1 ml IPPVO on days 0, 2 and 9 subcutaneously in addition to amitraz (0.025 %) treatment twice weekly for 80 days. IGF-1, IGF-2, EGF and VEGF concentrations in blood serum were measured by canine-specific enzyme-linked immunosorbent assay kit.  EGF, VEGF, IGF-1, and IGF-2 expressions in skin biopsy specimens were examined immunohistochemically. Results. After the treatment of the dogs with amitraz plus-IPPVO in GD, we demonstrated a significant reduction in both circulating concentrations and skin expressions of EGF, VEGF, IGF-1, and IGF-2, which have a role in preserving skin integrity and wound healing. Conclusions. Results of this study suggest that IGF-1, IGF-2 EGF, and VEGF have a crucial role in the progression of GD in dogs. It is believed that the findings from this study will contribute to the development of new strategies for the treatment of GD, which is an important health problem for dogs.


Article visits 293 | PDF visits


Downloads

Download data is not yet available.
  1. Gross TL, Ihrke PJ, Walder EJ, Affolter VK. Skin Diseases of the Dog and Cat. Clinical and Histopathologic Diagnosis. Blackwell Publishing: UK; 2005.
  2. Scott DW, Miller WH, Griffin CE. Parasitic skin diseases. Small animal dermatology. Muller GH and Kirk RW (eds), W.B. Saunders Co: Philadelphia; 2001.
  3. Day MJ. An immunohistochemical study of the lesions of demodicosis in the dog. J Comp Pathol. 1997; 116:203-216. https://doi.org/10.1016/S0021-9975(97)80077-1
  4. Shipstone M. Generalised demodicosis in dogs, clinical perspective. Aust Vet J. 2000; 78:240-242. https://doi.org/10.1111/j.1751-0813.2000.tb11741.x
  5. Tarallo VD, Lia RP, Sasanelli M, Cafarchia C, Otranto D. Efficacy of Amitraz plus Metaflumizone for the treatment of canine demodicosis associated with Malassezia pachydermatis. Parasit Vectors. 2009; 2:13. http://https//doi.org/10.1186/1756-3305-2-13
  6. Fourie J, Dumont P, Halos L, Beugnet F, Pollmeier M. Efficacy of a topical application of Certifect(R) (fipronil 6.26% w/v, amitraz 7.48% w/v, (S)-methoprene 5.63% w/v) for the treatment of canine generalized demodicosis. Parasite 2013; 20:46. https://doi.org/10.1051/parasite/2013046
  7. Pekmezci D, Pekmezci GZ, Guzel M, Cenesiz S, Gurler AT, Gokalp G. Efficacy of amitraz plus inactivated Parapoxvirus ovis in the treatment of canine generalised demodicosis. Vet Rec. 2014; 174:556. https://doi.org/10.1136/vr.102226
  8. Gartner MH, Benson JD, Caldwell MD. Insulin-like growth factors I and II expression in the healing wound. J Surg Res. 1992; 52:389-394. https://doi.org/10.1016/0022-4804(92)90121-F
  9. Corral CJ, Siddiqui A, Wu L, Farrell CL, Lyons D, Mustoe TA. Vascular endothelial growth factor is more important than basic fibroblastic growth factor during ischemic wound healing. Arch Surg. 1999; 134:200-205. http://dx.doi.org/10.1001/archsurg.134.2.200
  10. Gibbs S, Silva Pinto AN, Murli S, Huber M, Hohl D, Ponec M. Epidermal growth factor and keratinocyte growth factor differentially regulate epidermal migration, growth, and differentiation. Wound Repair Regen. 2000; 8:192-203. https://doi.org/10.1046/j.1524-475x.2000.00192.x
  11. Bao P, Kodra A, Tomic-Canic M, Golinko MS, Ehrlich HP, Brem H. The role of vascular endothelial growth factor in wound healing. J Surg Res. 2009; 153:347-358. https://doi.org/10.1016/j.jss.2008.04.023
  12. Shirakata Y. Regulation of epidermal keratinocytes by growth factors. J Dermatol Sci. 2010; 59:73-80. https://doi.org/10.1016/j.jdermsci.2010.05.002
  13. Talebpour Amiri F, Fadaei Fathabadi F, Mahmoudi Rad M, Piryae A, Ghasemi A, Khalilian A, Yeganeh F, Mosaffa N. The effects of insulin-like growth factor-1 gene therapy and cell transplantation on rat acute wound model. Iran Red Crescent Med J. 2014; 16(10):e16323. https://doi.org/10.5812/ircmj.16323
  14. Wu Z, Tang Y, Fang H, Su Z, Xu B, Lin Y, Zhang P, Wei X. Decellularized scaffolds containing hyaluronic acid and EGF for promoting the recovery of skin wounds. J Mater Sci Mater Med. 2015; 1:5322. https://doi.org/10.1007/s10856-021-06531-9
  15. Acosta JB, Savigne W, Valdez C, Franco N, Alba JS, del Rio A, López-Saura P, Guillén G, Lopez E, Herrera L, Férnandez-Montequín J. Epidermal growth factor intralesional infiltrations can prevent amputation in patients with advanced diabetic foot wounds. Int Wound J. 2006; 3:232-239. https://doi.org/10.1111/j.1742-481X.2006.00237.x
  16. Hong JP, Jung HD, Kim YW. Recombinant human epidermal growth factor (EGF) to enhance healing for diabetic foot ulcers. Ann Plast Surg. 2006; 56:394-398. https://doi.org/10.1097/01.sap.0000198731.12407.0c
  17. Frank S, Hübner G, Breier G, Longaker MT, Greenhalgh DG, Werner S. Regulation of vascular endothelial growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing. J Biol Chem. 1995; 270:12607-12613. https://doi.org/10.1074/jbc.270.21.12607
  18. Iijima K, Yoshikawa N, Connolly DT, Nakamura H. Human mesangial cells and peripheral blood mononuclear cells produce vascular permeability factor. Kidney Int. 1993; 44:959-966. https://doi.org/10.1038/ki.1993.337
  19. Boocock CA, Charnock-Jones DS, Sharkey AM, McLaren J, Barker PJ, Wright KA, Twentyman PR, Smith SK. Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma. J Natl Cancer Inst. 1995; 87:506-516. https://doi.org/10.1093/jnci/87.7.506
  20. Gerber HP, Vu TH, Ryan AM, Kowalski J, Werb Z, Ferrara N. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med. 1999; 6:623-628. https://doi.org/10.1038/9467
  21. Bates DO, Beazley-Long N, Benest AV, Ye X, Ved N, Hulse RP, Barratt S, Machado MJ, Donaldson LF, Harper SJ, Peiris-Pages M, Tortonese DJ, Oltean S, Foster RR. Physiological role of vascular endothelial growth factors as homeostatic regulators. Compr Physiol. 2018; 8:955-979. https://doi.org/10.1002/cphy.c170015
  22. Zachary I. Molecules in focus VEGF. Int J Biochem Cell Biol. 1998; 30:1169-1174. https://doi.org/10.1016/S1357-2725(98)00082-X
  23. Yoo H, Kim SJ, Kim Y, Lee H, Kim TY. Insulin-like growth factor-II regulates the 12-lipoxygenase gene expression and promotes cell proliferation in human keratinocytes via the extracellular regulatory kinase and phosphatidylinositol 3-kinase pathways. Int J Biochem Cell Biol. 2007; 39:1248-1259. https://doi.org/10.1016/j.biocel.2007.04.009
  24. Bohnsack RN, Warejcka DJ, Wang L, Gillespie SR, Bernstein AM, Twining SS, Dahms NM. Expression of insulin-like growth factor 2 receptor in corneal keratocytes during differentiation and in response to wound healing. Invest Ophthalmol Vis Sci. 2014; 55:7697-7708. https://doi.org/10.1167/iovs.14-15179
  25. Dong ZZ, Yao M, Qian J, Yan XD, Chen J, Yan MJ, Yao NH, Yao DF. Abnormal expression of insulin-like growth factor-II and intervening of its mRNA transcription in the promotion of HepG2 cell apoptosis. Zhonghua Yi Xue Za Zhi. 2013; 93:892-896. https://doi.org/10.3760/cma.j.issn.0376-2491.2013.12.004
  26. Tani K, Morimoto M, Hayashi T, Inokuma H, Ohnishi T, Hayashiya S, Nomura T, Une S, Nakaichi M, Taura Y. Evaluation of cytokine messenger RNA expression in peripheral blood mononuclear cells from dogs with canine demodicosis. J Vet Med Sci. 2002; 64:513-518. https://doi.org/10.1292/jvms.64.513
  27. Yarim GF, Yagci BB, Ciftci G. Increased circulating concentrations of PDGF-BB and TGF-β1 in canine generalised demodicosis. Rev Med Vet. 2013; 164:13-17. https://www.researchgate.net/publication/283055446
  28. Yarim GF, Yagci BB, Yarim M, Sozmen M, Pekmezci D, Cenesiz S, Pekmezci GZ, Karaca E. Serum concentration and skin tissue expression of insulin-like growth factor 2 in canine generalized demodicosis. Vet Dermatol. 2015; 26: 421–e99. https://doi.org/10.1111/vde.12270
  29. Pereira AV, Pereira SA, Gremião IDF, Campos MP, Ferreira AMR. Comparison of acetate tape impression with squeezing versus skin scraping for the diagnosis of canine demodicosis. Aust Vet J. 2012; 90:448-450. https://doi.org/10.1111/j.1751-0813.2012.00994.x
  30. Kuznetsova E, Bettenay S, Nikolaeva L, Majzoub M, Mueller R. Influence of systemic antibiotics on the treatment of dogs with generalized demodicosis. Vet Parasitol. 2012; 188:148-155. https://doi.org/10.1016/j.vetpar.2012.02.023
  31. Lu Z, Weniger M, Jiang K, Boeck S, Zhang K, Bazhin A, Miao Y, Werner J, D'Haese JG. Therapies targeting the tumor stroma and the VEGF/VEGFR axis in pancreatic ductal adenocarcinoma: a systematic review and meta-analysis. Target Oncol. 2018; 13:447-459. https://doi.org/10.1007/s11523-018-0578-x
  32. Wu Q, Wang JH, Li ZQ, Ren JL, Wu YH. Expression of vascular endothelial growth factor in deep second-degree scald wounds in rats. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2014; 36:650-653. https://doi.org/10.3881/j.issn.1000-503X.2014.06.017
  33. Sobczyńska-Rak A, Polkowska I, Silmanowicz P. Elevated Vascular Endothelial Growth Factor (VEGF) levels in the blood serum of dogs with malignant neoplasms of the oral cavity. Acta Vet Hung. 2014; 62:362-371. https://doi.org/10.1556/avet.2014.009
  34. Balicki I, Sobczyńska-Rak A. Serum vascular endothelial growth factor concentration in dogs diagnosed with chronic superficial keratitis. Acta Vet Hung. 2014; 62:22-32. https://doi.org/10.1556/avet.2013.040
  35. Mukorera V, Kirberger RM, Mabeta P, Dvir E. Vascular endothelial growth factor concentrations in dogs with spirocercosis. J Vet Intern Med. 2013; 27:1642-1645. https://doi.org/10.1111/jvim.12179
  36. Neely EK, Morhenn VB, Hintz RL, Wilson DM, Rosenfeld RG. Insulin-like growth factors are mitogenic for human keratinocytes and a squamous cell carcinoma. J Invest Dermatol. 1991; 96:104-110. https://doi.org/10.1111/1523-1747.ep12515914
  37. Maeng YS, Choi HJ, Kwon JY, Park YW, Choi KS, Min JK, Kim YH, Suh PG, Kang KS, Won MH, Kim YM, Kwon YG. Endothelial progenitor cell homing: prominent role of the IGF2-IGF2R-PLCbeta2 axis. Blood. 2009; 113:233-243. https://doi.org/10.1182/blood-2008-06-162891

Sistema OJS 3.4.0.3 - Metabiblioteca |